Literature DB >> 32294352

Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.

H Gilbert Welch1, Peter C Albertsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32294352     DOI： 10.1056/NEJMms1914228

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

1.  Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer.

Authors:  Jiun-Hung Geng; Anna Plym; Kathryn L Penney; Mark Pomerantz; Lorelei A Mucci; Adam S Kibel
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-01-24       Impact factor: 5.554

2.  Metastatic Prostate Adenocarcinoma: A Rare Presentation.

Authors:  Pierre Rodriguez; Katayoun Khoshbin; Jay Vakil; Vaishali Deenadayalan; Ekrem Turk
Journal:  Cureus       Date:  2022-01-16

Review 3.  Bone Health in Patients With Prostate Cancer: An Evidence-Based Algorithm.

Authors:  Eric D Johnson; Katerina Butler; Sumati Gupta
Journal:  Fed Pract       Date:  2021-08

4.  Outcomes of Screening for Prostate Cancer Among Men Who Use Statins.

Authors:  Arla Vettenranta; Teemu J Murtola; Jani Raitanen; Paavo Raittinen; Kirsi Talala; Kimmo Taari; Ulf-Håkan Stenman; Teuvo L J Tammela; Anssi Auvinen
Journal:  JAMA Oncol       Date:  2022-01-01       Impact factor: 31.777

Review 5.  Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.

Authors:  Hendrik Van Poppel; Tit Albreht; Partha Basu; Renée Hogenhout; Sarah Collen; Monique Roobol
Journal:  Nat Rev Urol       Date:  2022-08-16       Impact factor: 16.430

Review 6.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

7.  Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia.

Authors:  Joshua D Cohen; Brenda Diergaarde; Nickolas Papadopoulos; Kenneth W Kinzler; Robert E Schoen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-08       Impact factor: 4.254

8.  Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study.

Authors:  Youyan Guan; Xiaobing Wang; Kaopeng Guan; Dong Wang; Xingang Bi; Zhendong Xiao; Zejun Xiao; Xingli Shan; Linjun Hu; Jianhui Ma; Changling Li; Yong Zhang; Jianzhong Shou; Baiyun Wang; Ziliang Qian; Nianzeng Xing
Journal:  BMC Med Genomics       Date:  2022-05-05       Impact factor: 3.622

9.  An Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer.

Authors:  Shuo Wang; Wei Su; Chuanfan Zhong; Taowei Yang; Wenbin Chen; Guo Chen; Zezhen Liu; Kaihui Wu; Weibo Zhong; Bingkun Li; Xiangming Mao; Jianming Lu
Journal:  Front Cell Dev Biol       Date:  2020-12-10

10.  An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.

Authors:  Michael B Cook; Lauren M Hurwitz; Ashley M Geczik; Eboneé N Butler
Journal:  Eur Urol       Date:  2020-10-20       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.